Infliximab therapy in rheumatoid arthritis and ankylosing spondylitis-induced specific antinuclear and antiphospholipid autoantibodies without autoimmune clinical manifestations: a two-year prospective study

Treatment of rheumatoid arthritis (RA) with infliximab (Remicade(®)) has been associated with the induction of antinuclear autoantibodies (ANA) and anti-double-stranded DNA (anti-dsDNA) autoantibodies. In the present study we investigated the humoral immune response induced by infliximab against org...

Descripción completa

Detalles Bibliográficos
Autores principales: Ferraro-Peyret, Carole, Coury, Fabienne, Tebib, Jacques G, Bienvenu, Jacques, Fabien, Nicole
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2004
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1064868/
https://www.ncbi.nlm.nih.gov/pubmed/15535831
http://dx.doi.org/10.1186/ar1440

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1064868/
https://www.ncbi.nlm.nih.gov/pubmed/15535831
http://dx.doi.org/10.1186/ar1440

Ejemplares similares